2025 AGENDA
We're looking forward to seeing you at the 14th Annual Texas Life Science Forum on Tuesday, November 11, 2025. Registration is currently open and we hope to see you there!
2025 Texas Life Science Forum Agenda
-
-
Jeff Wade, JD, Chairman, BioHouston
Brad Burke, Associate Vice President, Industry & New Ventures, Rice Innovation, Ion; Executive Director, Rice Alliance for Technology and Entrepreneurship
-
Bill McKeon, President and CEO, Texas Medical Center
-
Introduction: Patrick Clayton, VP, Life Sciences and Healthcare Startup Banking, J.P. Morgan
Moderator: Annie Sendejo, VP Life Sciences Banking, J.P. Morgan
Barbara Alcaraz Silva, PhD, Executive Director, Life Sciences and Healthcare Startup Banking, J.P. Morgan
Sean MacGregor, Executive Director, Healthcare Investment Banking, J.P. Morgan -
-
-
-
Michael Torosian, JD, Partner, Baker Botts
-
Sarah Hein, PhD, Cofounder & CEO, March Biosciences (2024 TLSF Most Promising Company)
Suma Gopinathan, PhD, Senior Vice President, Discovery, Lexicon Pharmaceuticals (Nasdaq: LXRX)
-
-
Kristen Doyle, CEO, Cancer Prevention and Research Institute of Texas (CPRIT)
Victoria Ford, CEO, Texas Healthcare and Bioscience Institute
Ken Smith, Chief Product Development Officer, Cancer Prevention and Research Institute of Texas (CPRIT) -
-
-
-
Pothik Chatterjee, MBA, Executive Director, Digital Health Institute, Rice University and Methodist Hospital
-
-
Raymond Miller, Partner, U.S. Chair, Life Sciences Patent Development and Strategy, DLA Piper
-
Moderator: Verena Kallhoff, PhD, Sr. Director, Global Life Sciences, Greater Houston Partnership
-
Moderator: Suzanne Tomlinson-Mathis, Director, Research Programs and Strategic Initiatives, Gulf Coast Consortia for Quantitative Biomedical Science
Panelists:
Emily Barnhill, MHA, Vice President, Strategic Industry Ventures, MD Anderson
Bruce Butler, PhD, Vice President, Research and Technology Director, Office of Technology Management, UT Health
Vineet Gupta, PhD, Vice President for Innovation & Tech Development & Transfer, UTMB
Joe Petrosino, PhD, Chief Scientific Innovation Officer, Baylor College of Medicine
-
-
-
-
Bob Radinsky, PhD, Vice President, Global Head, Oncology External Innovation, Johnson & Johnson
-
- 10 Most Promising Life Science Companies - Presented by Greater Houston Partnership
- Michael E. DeBakey Award - Presented by BioHouston
- People’s Choice Award
-
- 10 Most Promising Life Science Companies - Presented by Greater Houston Partnership
- Michael E. DeBakey Award - Presented by BioHouston
- People’s Choice Award
Make It a Week: Engage with the Life Science Ecosytem
Our partners in the community will also be hosting multiple events throughout the week! Learn more about each and register below!
Nov. 10: The Houston Angel Network’s “Startup Essentials: Navigate, Grow, Fund” at Texas A&M’s EnMed.
5:00 PM - 6:00 PM: Registration & Networking
6:10 PM - 6:30 PM: Introduction and Keynote
6:30 PM - 7:15 PM: Bridging the Funding Gap: Angels, Family Offices, Nondilutive Funding
7:15 PM - 8:00 PM: Startup Fundamentals: From Idea to Exit
Nov. 11: The 14th Annual Texas Life Science Forum at Rice University
Nov. 12: Envision 2025:
Showcasing Healthcare Innovation at TMC Innovation. Showcasing Healthcare Innovation at TMC Innovation. Envision 2025 brings together the TMC community to reimagine the future of healthcare - inside the hospital, across communities, and through the lens of policy. Through thought-provoking discussions and visionary perspectives, the event will highlight how innovation is shaping care delivery, population health and the policies driving change.
Nov. 12: CPRIT Investor Day at JLABS (Semi-Private):
Investors and CPRIT-backed companies, mark your calendars for CPRIT Investor Day on Wednesday, November 12, hosted by Johnson & Johnson at JLABS TMC. This exclusive, curated event offers a rare opportunity for strategic investors and venture capitalists to connect with rigorously vetted, high-potential startups backed by the Cancer Prevention and Research Institute of Texas (CPRIT). The day will include a networking lunch, expert panel discussions, and 1:1 conversations with leading oncology startups, funding partners and J&J oncology leadership.
Those interested in attending should reach out directly to aaguir48@its.jnj.com for availability.